The Asturias Civil Guard has donated 100 nozzles of ethyl meters to the Asturian researchers who have developed a prototype of a respirator that could be used in Spanish hospitals to alleviate the effects of the Covid-19. The respirator has been created by 3D printing and in the next few days it will be clinically tested at the Central University Hospital of Asturias (HUCA).
As reported by the Civil Guard, this Thursday at 9:30 p.m. a representative of the company contacted the Traffic Group of the Civil Guard of Asturias, informing them that they are developing a project to manufacture artificial respirators.
During the call, the investigator revealed the need to one last piece that they couldn’t acquire. The researchers reported that using the mouthpieces of the ethyl meters currently used by the Traffic Group could solve this problem.
For this reason, “and in view of the urgency of this project,” at 11:15 p.m. two Civil Guard officers came to the place where the researchers were developing the prototype with 100 nozzles of ethometers.
The @Civil Guard of traffic of Asturias has collaborated with a company that develops a design of artificial respirators. He has donated 100 mouthpieces from the alcohol testers. They needed a part that was impossible to acquire and the nozzles can replace it. pic.twitter.com/Wjjffcw6Jc
– Civil Guard ???? (@Civil Guard) March 21, 2020
The group working on this project is led by the computer engineer Marcos Castillo, the mechanical engineer Juan María Piñera Parrilla, the electronic engineer Carlos Moreno-Luque Suárez and the 3D specialist Bartolomé López Medina. Resistencia Team has been researching and working on the development of this respirator since the state of alarm was declared.
They have generated open source documentation so that anyone with 3D printer can print the parts from anywhere and automatic respirators are developed that can donate to local health services.
The prototype has been developed following the technical aspects required for this type of respirator. However, the most important part remains, the clinical assessment by HUCA to verify that the device is viable and can be applied in ICUs.